Valsartan and hepatic function abnormal Patient Reports February 11, 2012

Valsartan Side Effects Report #5256012-1
Valsartan side effect was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, hepatic function abnormal, ocular discomfort, vogt-koyanagi-harada syndrome. Valsartan dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5269555-1
Valsartan side effect was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, condition aggravated, diabetes mellitus, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, vogt-koyanagi-harada syndrome. Valsartan dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5272445-1
Valsartan side effect was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: condition aggravated, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, vogt-koyanagi-harada syndrome. Valsartan dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5285948-0
Valsartan side effect was reported by a Physician from JAPAN on Mar 22, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, vogt-koyanagi-harada syndrome. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.


Valsartan Side Effects Report #5317464-1
Valsartan side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: choroidal detachment, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, optic nerve disorder. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5353430-8
Valsartan side effect was reported by a Physician from JAPAN on June 01, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: choroidal detachment, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, optic nerve disorder. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5374364-9
Valsartan side effect was reported by a Physician from JAPAN on June 21, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: choroidal detachment, constipation , csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5381498-1
Valsartan side effect was reported by a Physician from JAPAN on June 29, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: choroidal detachment, constipation , csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Valsartan Side Effects Report #5419129-4
Valsartan side effect was reported by a Physician from JAPAN on Aug 07, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: choroidal detachment, constipation , csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.


Valsartan Side Effects Report #5505509-5
Valsartan side effect was reported by a Physician from JAPAN on Oct 25, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Valsartan. After drug was administered, patient experienced the following side effects: choroidal detachment, constipation , csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. Valsartan dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.